Piscataqua Savings Bank’s Cardiol Therapeutics CRDL Stock Holding History

Piscataqua Savings Bank’s Portfolio CRDL Stock Details CRDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3K	Hold	5,000	–	–	0.01%	345
2026 Q1	$10.3K	Hold	5,000	–	–	0.01%	336
2025 Q4	$10.3K	Hold	5,000	–	–	0.01%	327
2025 Q3	$10.3K	Hold	5,000	–	–	0.01%	282
2025 Q2	$10.3K	Hold	5,000	–	–	0.01%	282
2025 Q1	$10.3K	Hold	5,000	–	–	0.01%	266
2024 Q4	$10.3K	Hold	5,000	–	–	0.01%	269
2024 Q3	$10.3K	Hold	5,000	–	–	0.01%	271
2024 Q2	$10.3K	Buy	5,000 +2,000	+67%	+$4.24K	0.01%	264
2024 Q1	$6.15K	Hold	3,000	–	–	0.01%	294
2023 Q4	$2.52K	Hold	3,000	–	–	﹤0.01%	320
2023 Q3	$2.67K	Hold	3,000	–	–	﹤0.01%	319
2023 Q2	$2.67K	Hold	3,000	–	–	﹤0.01%	315
2023 Q1	$1.44K	Hold	3,000	–	–	﹤0.01%	337
2022 Q4	$1.53K	Buy	+3,000	New	+$1.83K	﹤0.01%	327
2021 Q4	–	Sell	-1,000	Closed	-$4K	–	341
2021 Q3	$4K	Buy	+1,000	New	+$3.62K	﹤0.01%	306

Other funds holding CRDL

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Piscataqua Savings Bank's CRDL Position: Q2 2026 in Review

Piscataqua Savings Bank held its Cardiol Therapeutics (CRDL) position steady in Q2 2026 at 5,000 shares worth $10.3K. The position accounts for 0.01% of the portfolio, ranked #345.

Piscataqua Savings Bank first reported a position in CRDL in Q3 2021 and has held it in 16 quarters since. 3 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

Piscataqua Savings Bank held 5,000 shares of Cardiol Therapeutics worth $10.3K as of Q2 2026.
Piscataqua Savings Bank left its Cardiol Therapeutics share count unchanged in Q2 2026.
Cardiol Therapeutics made up 0.01% of Piscataqua Savings Bank's portfolio in Q2 2026, its #345 holding.
Piscataqua Savings Bank first reported a position in Cardiol Therapeutics in Q3 2021 and has held it in 16 quarters since.
3 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.